Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma.
JAMA Netw Open
; 4(3): e213497, 2021 03 01.
Article
in En
| MEDLINE
| ID: mdl-33779744
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organ Transplantation
/
Quality-Adjusted Life Years
/
Clinical Decision-Making
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
JAMA Netw Open
Year:
2021
Document type:
Article
Affiliation country:
Países Bajos
Country of publication:
Estados Unidos